Hodges Michelle A 4

4 · QuidelOrtho Corp · Filed Feb 2, 2026

AI-generated summary of this filing

Updated Feb 3, 2026

QuidelOrtho (QDEL) CLO Michelle Hodges Receives RSU Award; Tax Withholding

What Happened

Michelle A. Hodges, Chief Legal Officer of QuidelOrtho (QDEL), had 7,836 restricted stock units (RSUs vest) on January 29, 2026. The RSUs converted to common shares (derivative conversion at $0.00).
To satisfy tax withholding obligations, 3,072 of those shares were retained by the company (disposed) at a per-share price of $27.41, equal to approximately $84,204 withheld. The net result: 7,836 RSUs vested, with a portion surrendered to cover taxes.

Key Details

Transaction date: January 29, 2026 (Filed February 2, 2026 — within the required reporting window).
Actions reported: A (award/vesting) — 7,836 RSUs; M (conversion/exercise of derivative) — 7,836 shares converted; F (tax withholding) — 3,072 shares withheld/disposed at $27.41 each (~$84,204).
Vesting schedule noted: 7,836 vested on 1/29/2026; 7,836 will vest on 1/29/2027; 7,837 will vest on 1/29/2028.
Beneficial ownership note: The filing states post-transaction beneficial ownership includes an additional 561 shares purchased under the company’s Employee Stock Purchase Plan (ESPP).
Footnotes clarify that the release of RSUs was previously reported, each RSU equals one share, and the share disposition was solely to satisfy tax withholding (net share settlement), not an open-market sale.

Context

This was a routine RSU vesting and net-share settlement to satisfy tax obligations — not an open-market sell or a new purchase. Net withholding of shares for taxes is common and does not necessarily indicate a change in insider sentiment.
The filing shows conversion/exercise of RSUs (derivative to common stock) and net-share tax withholding; no 10b5‑1 plan or gift was reported.

Form 4

Period: 2026-01-29

Chief Legal Officer

Transactions

Award
Common Stock
[F1][F2]
2026-01-29+7,836→ 40,432 total
Tax Payment
Common Stock
[F3]
2026-01-29$27.41/sh−3,072$84,204→ 37,360 total
Exercise/Conversion
Restricted Stock Units
[F4][F5]
2026-01-29−7,836→ 15,673 total
→ Common Stock (7,836 underlying)

Footnotes (5)

[F1]Reflects release of restricted stock units that were previously reported on a Form 4.
[F2]The amount of shares beneficially owned following this transaction includes an additional 561 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
[F3]Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
[F4]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
[F5]7,836 shares vested on January 29, 2026; 7,836 shares will vest on January 29, 2027; and the remaining 7,837 shares will vest on January 29, 2028.

Signature

/s/ Phillip S. Askim, attorney-in-fact for Michelle A. Hodges|2026-02-02

1 file